T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Chewy
CHWY
$9.2B
| $6.03M | ﹤0.01% |
182,303
+13,532
| +8% | +$470K |
|
1327
Glacier Bancorp
GBCI
$6.48B
| $6M | ﹤0.01% |
136,108
+13,131
| +11% | +$576K |
|
1328
Ryder
R
$10.1B
| $5.93M | ﹤0.01% |
30,965
+481
| +2% | +$86.4K |
|
1329
GATX Corp
GATX
$6.34B
| $5.89M | ﹤0.01% |
34,747
+1,053
| +3% | +$174K |
|
1330
DNOW Inc
DNOW
$3.04B
| $5.89M | ﹤0.01% |
444,641
+116,032
| +35% | +$1.63M |
|
1331
DaVita
DVA
$11.6B
| $5.89M | ﹤0.01% |
51,801
-8,276
| -14% | -$1.01M |
|
1332
NNN REIT
NNN
$8.79B
| $5.88M | ﹤0.01% |
148,413
-409,489
| -73% | -$16.8M |
|
1333
GFL Environmental
GFL
$14.7B
| $5.86M | ﹤0.01% |
136,487
+10,514
| +8% | +$470K |
|
1334
Essent Group
ESNT
$6.14B
| $5.84M | ﹤0.01% |
89,837
-62,229
| -41% | -$3.86M |
|
|
SEE
1335
DELISTED
Sealed Air
SEE
| $5.84M | ﹤0.01% |
140,942
-3,138,011
| -96% | -$121M |
|
|
MIAX
1336
Miami International Holdings
MIAX
$4.36B
| $5.79M | ﹤0.01% |
130,486
-268,296
| -67% | -$12M |
|
1337
Kaspi.kz JSC
KSPI
$18.9B
| $5.79M | ﹤0.01% |
74,048
-24,950
| -25% | -$1.89M |
|
|
OTF
1338
Blue Owl Technology Finance Corp
OTF
$5.27B
| $5.76M | ﹤0.01% |
396,454
+234,268
| +144% | +$3.29M |
|
|
TMHC
1339
DELISTED
Taylor Morrison
TMHC
| $5.75M | ﹤0.01% |
97,571
+2,215
| +2% | +$135K |
|
1340
Qorvo
QRVO
$8.67B
| $5.73M | ﹤0.01% |
67,827
+1,216
| +2% | +$107K |
|
1341
Banco Bilbao Vizcaya Argentaria
BBVA
$158B
| $5.7M | ﹤0.01% |
+244,557
| New | +$5.11M |
|
1342
Eastman Chemical
EMN
$8.29B
| $5.68M | ﹤0.01% |
89,021
-79,294
| -47% | -$4.89M |
|
1343
Central Garden & Pet Co Class A
CENTA
$2.43B
| $5.57M | ﹤0.01% |
190,712
+12,366
| +7% | +$357K |
|
1344
LCI Industries
LCII
$2.6B
| $5.57M | ﹤0.01% |
45,869
-5,201
| -10% | -$553K |
|
|
AL
1345
DELISTED
Air Lease Corp
AL
| $5.53M | ﹤0.01% |
86,070
+3,464
| +4% | +$221K |
|
|
CRWV
1346
CoreWeave
CRWV
$58.6B
| $5.53M | ﹤0.01% |
77,184
+4,653
| +6% | +$472K |
|
1347
PVH
PVH
$3.76B
| $5.53M | ﹤0.01% |
82,422
+4,047
| +5% | +$317K |
|
1348
iShares Russell 2000 ETF
IWM
$82.4B
| $5.51M | ﹤0.01% |
22,397
+10,459
| +88% | +$2.57M |
|
1349
Commerce Bancshares
CBSH
$8.61B
| $5.51M | ﹤0.01% |
105,206
+8,307
| +9% | +$434K |
|
1350
Piper Sandler
PIPR
$5.34B
| $5.48M | ﹤0.01% |
64,520
+2,444
| +4% | +$206K |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.